Corcept Therapeutics, Inc. (CORT)
40.85
-1.64
(-3.86%)
USD |
NASDAQ |
Apr 06, 16:00
40.75
-0.10
(-0.24%)
After-Hours: 19:31
Corcept Therapeutics SG&A Expense (TTM) : 448.72M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Merck & Co., Inc. | 10.73B |
| Terns Pharmaceuticals, Inc. | 32.24M |
| Integer Holdings Corp. | 211.75M |
| Ultragenyx Pharmaceutical, Inc. | 350.06M |
| ACADIA Pharmaceuticals, Inc. | 548.89M |